Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bone Lengthening | 1 | 2021 | 2 | 0.710 |
Why?
|
| Leg | 1 | 2021 | 11 | 0.700 |
Why?
|
| Exercise | 5 | 2020 | 173 | 0.600 |
Why?
|
| Arthroscopy | 2 | 2014 | 2 | 0.550 |
Why?
|
| Insurance, Health, Reimbursement | 2 | 2014 | 3 | 0.550 |
Why?
|
| Space Flight | 4 | 2020 | 26 | 0.490 |
Why?
|
| Killer Cells, Natural | 3 | 2018 | 32 | 0.420 |
Why?
|
| Shoulder Joint | 4 | 2018 | 10 | 0.390 |
Why?
|
| Adult | 12 | 2021 | 1567 | 0.350 |
Why?
|
| Humans | 17 | 2021 | 4936 | 0.330 |
Why?
|
| Monocytes | 2 | 2018 | 18 | 0.280 |
Why?
|
| Shoulder Prosthesis | 2 | 2018 | 4 | 0.280 |
Why?
|
| Arthroplasty, Replacement, Shoulder | 2 | 2018 | 4 | 0.280 |
Why?
|
| Receptors, Adrenergic, beta-2 | 2 | 2018 | 11 | 0.280 |
Why?
|
| Treatment Outcome | 4 | 2021 | 177 | 0.250 |
Why?
|
| Male | 13 | 2020 | 2491 | 0.240 |
Why?
|
| Female | 12 | 2020 | 2523 | 0.230 |
Why?
|
| Astronauts | 3 | 2019 | 20 | 0.220 |
Why?
|
| Orthopedics | 2 | 2014 | 8 | 0.220 |
Why?
|
| Arthroplasty, Replacement | 2 | 2014 | 6 | 0.220 |
Why?
|
| Herpesviridae Infections | 2 | 2020 | 4 | 0.200 |
Why?
|
| Virus Activation | 2 | 2020 | 5 | 0.200 |
Why?
|
| Virus Latency | 2 | 2020 | 6 | 0.200 |
Why?
|
| Retrospective Studies | 2 | 2021 | 341 | 0.190 |
Why?
|
| Time Factors | 5 | 2020 | 163 | 0.180 |
Why?
|
| Leg Length Inequality | 1 | 2021 | 2 | 0.180 |
Why?
|
| Femur | 1 | 2021 | 4 | 0.180 |
Why?
|
| Bone Nails | 1 | 2021 | 5 | 0.180 |
Why?
|
| Lymphocyte Activation | 2 | 2018 | 15 | 0.180 |
Why?
|
| Herpesviridae | 1 | 2020 | 3 | 0.160 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2019 | 6 | 0.160 |
Why?
|
| Stress, Physiological | 1 | 2019 | 26 | 0.160 |
Why?
|
| Saliva | 1 | 2019 | 19 | 0.160 |
Why?
|
| Middle Aged | 6 | 2020 | 967 | 0.150 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2018 | 2 | 0.150 |
Why?
|
| Immunity, Humoral | 1 | 2018 | 2 | 0.150 |
Why?
|
| Immunoglobulins | 1 | 2018 | 3 | 0.150 |
Why?
|
| Fractures, Stress | 1 | 2018 | 1 | 0.150 |
Why?
|
| Scapula | 1 | 2018 | 2 | 0.150 |
Why?
|
| Lymphocytes | 1 | 2018 | 8 | 0.140 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2018 | 37 | 0.140 |
Why?
|
| Orthopedic Procedures | 2 | 2015 | 6 | 0.140 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2017 | 3 | 0.140 |
Why?
|
| Air Pollution, Indoor | 1 | 2015 | 1 | 0.120 |
Why?
|
| Housing, Animal | 1 | 2015 | 5 | 0.120 |
Why?
|
| Shoulder | 1 | 2015 | 2 | 0.110 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 5 | 0.110 |
Why?
|
| United States | 2 | 2014 | 495 | 0.110 |
Why?
|
| Bibliometrics | 1 | 2015 | 7 | 0.110 |
Why?
|
| Acromion | 1 | 2014 | 1 | 0.110 |
Why?
|
| Group Practice | 1 | 2014 | 1 | 0.110 |
Why?
|
| Macaca mulatta | 1 | 2015 | 111 | 0.110 |
Why?
|
| Workers' Compensation | 1 | 2014 | 1 | 0.110 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2014 | 1 | 0.110 |
Why?
|
| Clinical Coding | 1 | 2014 | 1 | 0.110 |
Why?
|
| Shoulder Pain | 1 | 2014 | 1 | 0.110 |
Why?
|
| Tendon Injuries | 1 | 2014 | 2 | 0.110 |
Why?
|
| Rotator Cuff | 1 | 2014 | 2 | 0.110 |
Why?
|
| Medicare | 1 | 2014 | 78 | 0.110 |
Why?
|
| Analgesics, Opioid | 1 | 2014 | 73 | 0.100 |
Why?
|
| Aged | 4 | 2018 | 703 | 0.100 |
Why?
|
| Statistics as Topic | 1 | 2011 | 8 | 0.090 |
Why?
|
| Oxygen Consumption | 1 | 2011 | 23 | 0.090 |
Why?
|
| Exercise Test | 1 | 2011 | 41 | 0.090 |
Why?
|
| Hydrocortisone | 2 | 2019 | 18 | 0.070 |
Why?
|
| Biomarkers | 2 | 2019 | 81 | 0.070 |
Why?
|
| K562 Cells | 2 | 2018 | 10 | 0.070 |
Why?
|
| Bisoprolol | 2 | 2018 | 9 | 0.070 |
Why?
|
| Double-Blind Method | 2 | 2018 | 32 | 0.070 |
Why?
|
| Nadolol | 2 | 2018 | 10 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2018 | 81 | 0.060 |
Why?
|
| Signal Transduction | 2 | 2018 | 216 | 0.060 |
Why?
|
| Heart Rate | 2 | 2018 | 43 | 0.060 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 262 | 0.060 |
Why?
|
| DNA, Viral | 1 | 2020 | 7 | 0.040 |
Why?
|
| alpha-Amylases | 1 | 2019 | 2 | 0.040 |
Why?
|
| Virus Shedding | 1 | 2019 | 2 | 0.040 |
Why?
|
| Immunoglobulin A, Secretory | 1 | 2019 | 4 | 0.040 |
Why?
|
| Cathelicidins | 1 | 2019 | 5 | 0.040 |
Why?
|
| Muramidase | 1 | 2019 | 32 | 0.040 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2018 | 2 | 0.040 |
Why?
|
| Immunoglobulin lambda-Chains | 1 | 2018 | 2 | 0.040 |
Why?
|
| Immunoglobulin A | 1 | 2018 | 4 | 0.040 |
Why?
|
| Immunoglobulin M | 1 | 2018 | 3 | 0.040 |
Why?
|
| Catecholamines | 1 | 2018 | 8 | 0.040 |
Why?
|
| Homeostasis | 1 | 2018 | 29 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2018 | 25 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2018 | 11 | 0.040 |
Why?
|
| Granulocytes | 1 | 2018 | 3 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2018 | 31 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2018 | 37 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2018 | 9 | 0.040 |
Why?
|
| Phenotype | 1 | 2018 | 67 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2018 | 7 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2018 | 12 | 0.040 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2018 | 19 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2018 | 39 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 160 | 0.030 |
Why?
|
| Humerus | 1 | 2017 | 1 | 0.030 |
Why?
|
| Peripheral Blood Stem Cells | 1 | 2017 | 2 | 0.030 |
Why?
|
| Radiography | 1 | 2017 | 6 | 0.030 |
Why?
|
| Antigens, CD34 | 1 | 2017 | 3 | 0.030 |
Why?
|
| Prosthesis Failure | 1 | 2017 | 5 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2017 | 4 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2017 | 4 | 0.030 |
Why?
|
| Adrenergic beta-2 Receptor Antagonists | 1 | 2017 | 5 | 0.030 |
Why?
|
| Range of Motion, Articular | 1 | 2017 | 9 | 0.030 |
Why?
|
| Reoperation | 1 | 2017 | 10 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2017 | 14 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 83 | 0.030 |
Why?
|
| Ventilation | 1 | 2015 | 1 | 0.030 |
Why?
|
| Carbon Dioxide | 1 | 2015 | 9 | 0.030 |
Why?
|
| Temperature | 1 | 2015 | 60 | 0.030 |
Why?
|
| Arm Injuries | 1 | 2015 | 1 | 0.030 |
Why?
|
| Authorship | 1 | 2015 | 4 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2015 | 10 | 0.030 |
Why?
|
| Health Status Indicators | 1 | 2014 | 8 | 0.030 |
Why?
|
| Rotator Cuff Injuries | 1 | 2014 | 2 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2014 | 2 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2014 | 111 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2011 | 30 | 0.020 |
Why?
|
| Spirometry | 1 | 2011 | 7 | 0.020 |
Why?
|
| Animals | 1 | 2015 | 1711 | 0.020 |
Why?
|